載入...
Evaluation of a Scaling Approach for the Bioequivalence of Highly Variable Drugs
Various approaches for evaluating the bioequivalence (BE) of highly variable drugs (CV ≥ 30%) have been debated for many years. More recently, the FDA conducted research to evaluate one such approach: scaled average BE. A main objective of this study was to determine the impact of scaled average BE...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer US
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2761698/ https://ncbi.nlm.nih.gov/pubmed/18726698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-008-9053-4 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|